PALSONIFY (paltusotine) for the Treatment of Acromegaly, USA
PALSONIFY™ (paltusotine) is a first-in-class, nonpeptide somatostatin receptor type 2 (SSTR2) agonist indicated as a first-line treatment for adults with acromegaly who either did not achieve satisfactory results from surgery or for whom surgery is …